Hyperprolactinaemia induced by antipsychotic drugs - the therapeutic role of cabergoline

被引：0
|
作者：
Kalkavouras, C [1 ]
Theodorou, A [1 ]
Papastamatis, K [1 ]
Tzebelikos, E [1 ]
机构：
[1] Sismanoglio Gen Hosp, Dept Psychiat, Athens, Greece
来源：
EUROPEAN PSYCHIATRY | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：171S / 172S
页数：2
相关论文
共 50 条
  • [21] Comment on hyperprolactinaemia and antipsychotic therapy in schizophrenia
    Howes, OD
    Smith, S
    Aitchison, KJ
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (10) : 1649 - 1649
  • [22] The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis
    Smith, S
    Wheeler, MJ
    Murray, R
    O'Keane, V
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (02) : 109 - 114
  • [23] Co-medication with psychotropic drugs, including antipsychotic drugs, and bromocriptine: changes in clinical signs of hyperprolactinaemia and prolactin level
    Barszcz, Zbigniew
    Mucha, Slawomir
    Rabe-Jabloska, Jolanta
    PSYCHIATRIA I PSYCHOLOGIA KLINICZNA-JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, 2007, 7 (03): : 154 - 164
  • [24] Antipsychotic-induced extrapyramidal symptoms - Role of anticholinergic drugs in treatment
    Barnes, TRE
    McPhillips, MA
    CNS DRUGS, 1996, 6 (04) : 315 - 330
  • [25] Therapeutic drug monitoring of atypical antipsychotic drugs
    Grundmann, Milan
    Kacirova, Ivana
    Urinovska, Romana
    ACTA PHARMACEUTICA, 2014, 64 (04) : 387 - 401
  • [26] Atypical antipsychotic-induced akathisia with depression: Therapeutic role of mirtazapine
    Ranjan, S
    Chandra, PS
    Chaturvedi, SK
    Prabhu, SC
    Gupta, A
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (04) : 771 - 774
  • [27] Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density
    Stubbs, B.
    JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING, 2009, 16 (09) : 838 - 842
  • [28] Doctors' understanding of antipsychotic-associated hyperprolactinaemia
    Walsh, James
    Lees, Emma
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2012, 16 (03) : 28 - 32
  • [29] ERP changes induced by antipsychotic drugs
    Mucci, A.
    Galderisi, S.
    Piccirillo, M.
    Merlotti, E.
    Maj, M.
    EUROPEAN PSYCHIATRY, 2008, 23 : S78 - S78
  • [30] Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia
    Tan, Tricia
    Cabrita, Ines Z.
    Hensman, Davina
    Grogono, Joanna
    Dhillo, Waljit S.
    Baynes, Kevin C.
    Eliahoo, Joseph
    Meeran, Karim
    Robinson, Stephen
    Nihoyannopoulos, Petros
    Martin, Niamh M.
    CLINICAL ENDOCRINOLOGY, 2010, 73 (03) : 369 - 374
12345